Singapore markets open in 4 hours 50 minutes
Straits Times Index
3,289.42 -23.93 (-0.72%) S&P 500
5,308.15 +61.47 (+1.17%) Dow
39,908.00 +349.89 (+0.88%) Nasdaq
16,742.39 +231.21 (+1.40%) Bitcoin USD
65,931.12 +4,381.52 (+7.12%) CMC Crypto 200
1,392.35 +124.40 (+9.81%)
IOVA Sep 2024 14.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 03:09PM EDT. Market open.
| Previous close | 1.3500 |
| Open | 1.3500 |
| Bid | 1.2000 |
| Ask | 1.3500 |
| Strike | 14.00 |
| Expiry date | 2024-09-20 |
| Day's range | 1.3000 - 1.3500 |
| Contract range | N/A |
| Volume | |
| Open interest | 1.9k |
GuruFocus.comIovance Biotherapeutics Inc (IOVA) Q1 2024 Earnings: Aligns with EPS Projections Amidst Strong ...
First Quarter Financials Reflect Strategic Expansion and Market Penetration
Insider MonkeyIovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q1 2024 Earnings Call Transcript
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q1 2024 Earnings Call Transcript May 9, 2024 Iovance Biotherapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to the Iovance Biotherapeutics Conference Call to discuss the First Quarter 2024 Results and recent Corporate […]
ZacksIovance (IOVA) Q1 Earnings Surpass, Sales Lag Estimates
Iovance (IOVA) reports mixed first-quarter results. Shares gain on encouraging initial demand for the recently-approved melanoma drug Amtagvi in the United States.
© 2024 Yahoo. All rights reserved.